209 related articles for article (PubMed ID: 16318875)
1. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
Yamada K; Watanabe K; Nemoto N; Fujita H; Chikaraishi C; Yamauchi K; Yagi G; Asai M; Kanba S
Psychiatry Res; 2006 Jan; 141(1):61-9. PubMed ID: 16318875
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia.
Rosa MA; Marcolin MA; Elkis H
Braz J Psychiatry; 2005 Sep; 27(3):178-84. PubMed ID: 16224604
[TBL] [Abstract][Full Text] [Related]
4. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride.
Linden M; Scheel T; Eich FX
J Psychopharmacol; 2006 Nov; 20(6):815-23. PubMed ID: 16401647
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
6. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
7. Attitudes toward medication in inpatients with schizophrenia: a cluster analytic approach.
Santone G; Rucci P; Muratori ML; Monaci A; Ciarafoni C; Borsetti G
Psychiatry Res; 2008 Apr; 158(3):324-34. PubMed ID: 18262656
[TBL] [Abstract][Full Text] [Related]
8. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
9. [Factors related to treatment adherence in schizophrenic patients].
García Cabeza I; Sánchez Díaz EI; Sanz Amador M; Gutiérrez Rodríguez M; González de Chávez M
Actas Esp Psiquiatr; 1999; 27(4):211-6. PubMed ID: 10469940
[TBL] [Abstract][Full Text] [Related]
10. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
11. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
12. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
Bachmann S; Bottmer C; Schroder J
Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
[TBL] [Abstract][Full Text] [Related]
13. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
15. Rating of medication influences (ROMI) scale in schizophrenia.
Weiden P; Rapkin B; Mott T; Zygmunt A; Goldman D; Horvitz-Lennon M; Frances A
Schizophr Bull; 1994; 20(2):297-310. PubMed ID: 7916162
[TBL] [Abstract][Full Text] [Related]
16. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.
Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM
Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182
[TBL] [Abstract][Full Text] [Related]
17. Understanding adherence to neuroleptic treatment in schizophreniaí.
Vauth R; Löschmann C; Rüsch N; Corrigan PW
Psychiatry Res; 2004 Apr; 126(1):43-9. PubMed ID: 15081626
[TBL] [Abstract][Full Text] [Related]
18. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Stanković Z; Britvić D; Vuković O; Ille T
Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
20. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
